We first noted that B cells of MS patients exhibit abnormally increased activation-induced expression of the costimulatory molecules CD80 and CD86 under the vehicle control condition (Fig. 5e, f), extending prior reports [16, 18]. This evidence concerns the gene CD86 and myeloid sarcoma.